News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Personnel
Flex Pharma Forms Distinguished Scientific Advisory Board 7/21/2014
Arno Therapeutics Appoints Alexander Zukiwski, M.D. As Interim Chief Executive Officer And Mr. Lawrence Kenyon As Chief Operating Officer 7/21/2014
Neogen Corporation (NEOG) COO Resigns 7/21/2014
iBio, Inc. (IBIO) Appoints Dr. Richard M. Silver To Clinical Advisory Board 7/21/2014
JDRF Appoints Derek Rapp As New President & CEO 7/21/2014
Milestone Pharmaceuticals Appoints Chief Medical Officer 7/21/2014
Theranos, Inc. Builds Pioneering Creative Organization, Appoints Patrick O'Neill As Chief Creative Officer 7/21/2014
American Osteopathic Association Installs Cleveland Clinic Executive Robert S. Juhasz, DO, As President 7/21/2014
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer 7/21/2014
WCCT Global Release: Contract Research Organization Welcomes Dr. Lani Clark As Head, Dermatology Clinical Research 7/18/2014
BioScrip (BIOS) Appoints Thomas Pettit As Senior Vice President And Chief Operating Officer 7/18/2014
Surpass, Inc. Announces Two Strategic Hires In Silicon Valley Facility And Launch Of Social Media Accounts 7/18/2014
Neurotrope Board Of Directors Appoints Chairmen Ramat And Freiman As Interim Co-CEOs 7/18/2014
Loxo Oncology Expands Leadership Team With Key Executive Appointments In Finance, R&D, And Corporate Development 7/17/2014
Zogenix, Inc. (ZGNX) Announces Appointment Of David Brushwood, J.D., R.Ph., To External Safe Use Board 7/17/2014
Aduro Biotech Names Industry Veteran And Academic Leader, Gerald Chan, DSc To Its Board Of Directors 7/17/2014
James Davis, Biotechnology Consultant, Elected Chair Of The Leukemia & Lymphoma Society's National Board Of Directors 7/17/2014
bluebird bio (BLUE) Appoints Mark Vachon To Its Board Of Directors 7/17/2014
Peptidream Announces The Appointment Of Dr. Keiichi Masuya As Chief Operating Officer (COO) At Peptidream Inc. 7/17/2014
Akebia Therapeutics, Inc. (AKBA) Appoints Michael Clayman, M.D. And Maxine Gowen, Ph.D. To Its Board Of Directors 7/17/2014
Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board 7/17/2014
BioUtah Selects Rich Linder As New Board Chair, George Hamilton As Vice Chair 7/17/2014
Evidera Strengthens European Presence With Senior Leader In Health Economics, Outcomes Research And Market Access 7/17/2014
Depomed, Inc. (DEPO) Announces Appointment Of Srinivas G. Rao, MD, PhD, As Chief Medical Officer 7/16/2014
DS Healthcare Appoints Mark Wolfson To Its Board Of Directors 7/16/2014
Alexion Pharmaceuticals Inc. (ALXN) Announces The Appointments Of David R. Brennan, M. Michele Burns And Christopher J. Coughlin To Its Board Of Directors 7/16/2014
Porter Novelli Appoints Dr. Amy Nicole Nayar Senior Vice President Of Global Health & Wellness 7/16/2014
Entest Biomedical, Inc. Recruits Salk Institute for Biological Studies Researcher To Lead Cancer Stem Cell Program For Treating Feline Leukemia And Canine Cancer 7/16/2014
iBio, Inc. (IBIO) Appoints Dr. Timothy Blackwell To New Clinical Advisory Board 7/16/2014
Aptuit LLC Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities 7/16/2014
MYOS (MYOS) Appoints World Renowned Scientific Visionary And Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors 7/15/2014
Deallus Consulting Appoints New CEO 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Repligen Corporation (RGEN) Hires Jon K. Snodgres As Chief Financial Officer 7/15/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
ACADIA Pharmaceuticals, Inc. (ACAD)Announces Appointment Of Stephen Davis As Executive Vice President, Chief Financial Officer And Chief Business Officer 7/15/2014
Malini Moorthy Joins Bayer Corporation (BAY) As U.S. Head Of Litigation 7/15/2014
CutisPharma Inc. Appoints Neal Muni, MD, MSPH as President 7/15/2014
Xencor Appoints Kurt Gustafson To Board Of Directors; Promotes John Desjarlais To Chief Scientific Officer 7/15/2014
Washington Biotechnology & Biomedical Association Announces New Appointments To Board Of Directors 7/15/2014
Illumina, Inc. (ILMN) Names Tina S. Nova As Senior Vice President And General Manager Of Oncology 7/15/2014
Mark H.N. Corrigan, M.D., Julie H. McHugh, And William Hunter, M.D. To Serve On EPIRUS Biopharmaceuticals Board Of Directors 7/15/2014
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014
Achaogen (AKAO) Appoints Dr. Ian Friedland As Chief Medical Officer 7/14/2014
Aastrom Biosciences, Inc. (ASTM) Announces Appointment Of Zac Taylor As National Sales Director 7/14/2014
Minerva Neurosciences, Inc. (NERV) Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 7/14/2014
Acceleron Pharma Appoints Terrence C. Kearney To Its Board Of Directors 7/14/2014
Cambridge Startup Jounce Therapeutics Snags Ex-Merck & Co., Inc. (MRK) Exec For CEO Post 7/11/2014
ScinoPharm President & CEO To Retire, Successor Named 7/11/2014
Medivation, Inc. (MDVN) Announces Change In Executive Management Team 7/11/2014
Transition Therapeutics Inc. (TTH.TO) Appoints Carl Damiani As Chief Operating Officer 7/11/2014
MonoSolRx LLC Appoints Joseph Crusco Director Of Business Development 7/10/2014
Intezyne Technologies LLC Expands Executive Leadership Team With Two Key Appointments 7/10/2014
Intercept Pharmaceuticals (ICPT) Names Lazar Partners Agency Of Record 7/10/2014
Vertex Pharmaceuticals (MA) (VRTX) Announces Retirement Of Peter Mueller, Ph.D. 7/10/2014
GlycoMimetics, Inc. (GLYC) Appoints Mark A. Goldberg, M.D. To Board of Directors 7/10/2014
Covance Inc. (CVD) Increases Its Medical And Scientific Leadership With Two Senior-Level Appointments 7/9/2014
FORUM Pharmaceuticals Appoints Christine Boisclair As Vice President, Regulatory Affairs 7/9/2014
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014
Cellectar Biosciences  (NVLT) Appoints Chad J. Kolean Chief Financial Officer 7/9/2014
Director Ying Han Resigns from WuXi PharmaTech Co., Ltd. Board 7/9/2014
Marken (Formerly known as Marken Time Critical) Appoints Paul J. Rice To Head EMEA Region 7/9/2014
Coherus Biosciences Appoints Dr. V. Bryan Lawlis, Jr. To Board Of Directors 7/9/2014
Professor Paul Workman Joins Nuevolution As Scientific Advisor 7/9/2014
Actavis (ACT) Execs Bag As Much As $186 Million In Merger Success Awards 7/9/2014
RestorGenex Announces Management Changes 7/9/2014
Boston Therapeutics, Inc. Appoints Benjamin Rivnay, Ph.D. To Chief Scientist 7/9/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Brings In Ex-Eisai Company, Ltd. (ESALY.PK) Exec As New President And CEO 7/8/2014
Raptor Pharmaceutical Inc. (RPTP) (RPTP) Names COO As Next CEO 7/8/2014
AAIPharma, Inc. Taps Stephan Kutzer As New CEO 7/8/2014
Activist Hedge Fund Proposes Six New Directors For Allergan Inc. (AGN) Board 7/8/2014
Vitae Pharmaceuticals, Inc. Adds To Leadership Team With Appointment Of Arthur Fratamico As Chief Business Officer, Richard Morris As Chief Financial Officer 7/8/2014
Glide Pharma Appoints Richard Bungay As Chief Financial Officer And Tony Mills As Director Of Business Development 7/8/2014
Lead Developer Of RTDS Technology To Take The Helm At Cibus Global 7/8/2014
Michael Balmuth Joins SV Life Sciences As Partner 7/8/2014
Veteran Microsoft Executive And Distinguished Engineer, Sean Nolan, Joins Adaptive Biotechnologies As Chief Technology Officer 7/8/2014
Nobel Laureate Roger Kornberg To Chair New ChromaDex, Inc. Scientific Advisory Board 7/8/2014
Oxford BioTherapeutics Appoints Dr. Eugen Leo As Head Of Clinical Development 7/8/2014
ContraVir Appoints Industry Veteran William Hornung As Its Chief Financial Officer 7/8/2014
Arch Therapeutics Appoints Richard Davis As Chief Financial Officer 7/8/2014
Baylor Oncology Medical Director Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab-B Scientific Advisory Board 7/8/2014
DermTech International Builds Commercialization Team 7/8/2014
Aerie Pharmaceuticals, Inc. (AERI) Expands Management Team, Names Michael McCleerey As Vice President, Marketing 7/8/2014
Baxter International, Inc. (BAX) Names Chief Financial Officers For New Biopharmaceutical Spin-Off And Baxter International Inc. 7/7/2014
StemCells Inc. (STEM) Appoints Dr. Alan Trounson To Board Of Directors 7/7/2014
ISA Pharmaceuticals Appoints Ronald Loggers As Chief Executive Officer 7/7/2014
RXi Pharmaceuticals (RXII) Appoints Peter Campochiaro M.D. To Its Scientific Advisory Board 7/7/2014
La Jolla Pharmaceutical Company (LJPC) Strengthens Board Of Directors With Appointment Of Robert H. Rosen 7/7/2014
Oxford Immunotec Limited (OXFD) Appoints Louis O'Dea Chief Medical Officer 7/7/2014
PCI Welcomes Tim Brown To Clinical Services Group 7/7/2014
Pharmalink AB Strengthens its Board Of Directors 7/7/2014
Diomics Announces New CSO Thomas Kindt, Ph.D. 7/7/2014
Theravance, Inc. (THRX) Appoints Theodore J. Witek, Jr. As Senior Vice President, Corporate Partnerships, Clinical And Medical Affairs 7/3/2014
PDI, Inc. (PDII) Announces Appointment Of Peter Cempellin And Patrick Treacy To Senior Leadership Roles 7/2/2014
Alnylam Pharmaceuticals (ALNY) Elects Amy Schulman To Its Board Of Directors 7/2/2014
Histogenics Corporation Announces Appointment Of Kathleen Large, R.N., M.S., To Vice President Of Clinical Operations 7/2/2014
MOCON Expands Board; Names Two New Directors To Its Board 7/2/2014
BioRestorative Therapies, Inc. Appoints Joseph B. Swiader To Its Board Of Directors 7/2/2014
Gail K. Naughton, PhD To Join Cytori Therapeutics, Inc. (CYTX)’ Board Of Directors 7/2/2014
Aesica Recruits New Business Development Manager To Aid Sales Drive Across German, Austrian And Swiss Markets 7/2/2014
Bellerophon Therapeutics Brings In Ex-Amgen (AMGN) Exec For CEO Post 7/2/2014
Applied Genetic Technologies Corporation Appoints Matthew Feinsod, MD, As Product Development Officer 7/1/2014
Zafgen (ZFGN) Appoints Patrick Loustau As President 7/1/2014
Bacterin International, Inc. Announces The Appointment Of Robert Di Silvio As President 7/1/2014
Paratek Pharmaceuticals, Inc. Taps A New CEO 7/1/2014
ALK-Abello A/S Appoints New Executive Vice President For Product Supply 7/1/2014
Avalanche Biotechnologies Announces Appointment Of Samuel B. Barone, M.D., As Chief Medical Officer 7/1/2014
Batu Biologics Recruits Renowned Cancer Immunologist To Scientific Advisory Board 7/1/2014
Kathy Giusti, Founder And CEO Of Multiple Myeloma Research Foundation (MMRF), Becomes Executive Chairman Of The MMRF Board Of Directors; Walter Capone Becomes President And CEO 7/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Promotion Of Edwin S. Kamemoto, Ph.D. To Senior Vice President, Regulatory Affairs 7/1/2014
Moderna Therapeutics, Inc. Appoints Oncology Leader Dr. Stephen Kelsey As President Of Onkaido Therapeutics 7/1/2014
Kinex Pharmaceuticals Appoints Mr. Michael Murphy To The Board Of Directors 7/1/2014
Actavis plc Appoints New Members And Announces Changes To Board Of Directors Following Close Of Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014
Parkinson's Disease Foundation Announces New Advisory Council Members 7/1/2014
Trevena, Inc. (TRVN) Appoints Julie H. Mchugh And Barbara Yanni To The Board Of Directors 7/1/2014
InVivo Therapeutics Corporation (NVIV) Appoints Christopher McNulty As Vice President, Business Development & Investor Relations 7/1/2014
Proteostasis Therapeutics, Inc. Brings In Meenu Chhabra As CEO 6/30/2014
ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments 6/30/2014
Applied Genetic Technologies Corporation Appoints David R. Guyer, MD, And Ivana Magovcevic-Liebisch, Phd, JD, To Its Board Of Directors 6/30/2014
Ipsen (IPN.PA) Joins PHARNEXT's Board Of Directors 6/30/2014
Nanomix, Inc. Appoints New CFO 6/30/2014
BioRestorative Therapies, Inc. Appoints The Honorable Paul Jude Tonna To Its Board Of Directors 6/30/2014
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. As Chief Medical Officer 6/30/2014
Synthetic Biologics, Inc. (SYN) Forms Clinical Advisory Board to Support Novel C. difficile Preventative Program 6/30/2014
CAPNIA, Inc. Appoints William G. Harris To Its Board Of Directors 6/30/2014
Hurel Corporation Announces Appointment Of Matthew K. Shipton As Head Of Sales And Marketing 6/27/2014
Pressure BioSciences, Inc. (BBII) Engages Issuworks In Strategic Advisory Role 6/27/2014
Zafgen (ZFGN) Appoints New Member Of Board Of Directors 6/27/2014
Chimerix, Inc. (CMRX) Mourns Passing Of Director Rodman L. Drake 6/27/2014
Tatjana Dragovic, J.D., Named Vice President, Regional Compliance Officer For Astellas In The Americas 6/27/2014
NMS Labs Dr. Barry Logan Appointed To National Institute of Standards and Technology Forensic Science Standards Board 6/27/2014
Astellas Appoints Marty Golden, J.D., As Vice President, Government Affairs 6/27/2014
Kolltan Pharmaceuticals Inc. Promotes Jane Henderson To Chief Financial And Business Officer And Expands Senior Team With Appointment Of Keith J. C. Darragh As Vice President Of Finance And Administration 6/27/2014
William Jeffrey Joins SRI International As President And CEO 6/26/2014
Celgene Corporation (CELG) Mourns The Passing Of Board Of Director Member, Rodman L. Drake 6/26/2014
Senesco Technologies, Inc. (SNT) Brings In A New CEO 6/26/2014
Cipher Pharmaceuticals (DND.TO) Grabs AltheRx's Ex-CEO Shawn Patrick O'Brien For Top Post 6/26/2014
Tris Pharma, Inc. Expands R&D Team With Addition Of Chief Medical Officer And Vice President Of Regulatory Affairs 6/26/2014
Bayer Corporation (BAY) Names Three To New U.S. Government Relations, External Communications Roles 6/26/2014
Esperion Therapeutics, Inc. (ESPR) Announces The Appointment Of Gilbert S. Omenn, M.D., Ph.D. To Board Of Directors 6/26/2014
Voyager Therapeutics Appoints Industry Veteran Robert G. Pietrusko, Pharm.D., To Senior Vice President Of Regulatory Affairs 6/26/2014
CompanionDx Reference Lab Expands Leadership Team 6/26/2014
James C. Smith Elected to Pfizer Inc. (PFE)’s Board of Directors 6/26/2014
Serial Entrepreneur Dr. Peter Hirth Joins Nuevolution As Corporate Advisor 6/26/2014
PixarBio Corporation Promotes Xi Chen To Director, Analytical Chemistry And Adds Haining Dai As Director, Pre-Clinical Neuroscience 6/26/2014
Industry Expert Carolyn Gudz Joins Expanding Confab Team 6/26/2014
HedgePath Pharmaceuticals Welcomes Three New Board Members 6/26/2014
Elsevier, Inc. Appoints Dr. Peter Edelstein As Chief Medical Officer 6/25/2014
Concord Medical Services Holdings Limited (CCM) Announces New Appointments to Management Team 6/25/2014
Inergetics, Inc. Names Jim Kras President 6/25/2014
InVivo Therapeutics Corporation (NVIV) Announces New Responsibilities For Senior Management Team Members 6/25/2014
OncoSec Medical Inc. Appoints Dr. Soldano Ferrone To Scientific Advisory Board 6/25/2014
Virobay Inc. Announces The Appointment Of James Welch As Chief Financial Officer 6/25/2014
CannLabs Announces Science Advisory Board Members 6/25/2014
Zosano Pharma, Inc. Appoints Troy Wilson, Ph.D., J.D., To Board Of Directors 6/25/2014
Evozym Biologics Announces Changes To Board Of Directors 6/25/2014
Epicypher Announces Sam Tetlow As CEO And Company Relocation To North Carolina 6/25/2014
ThromboGenics NV (TBGNF) Rules Out Sale, CFO Calls It Quits 6/24/2014
Genome-Editing Company Editas Medicine Brings In Ex-Avila Therapeutics CEO For Top Post 6/24/2014
Advanced Cell Technology Appoints Paul K. Wotton, Ph.D, President And CEO 6/24/2014
23andMe, Inc. Appoints Angela Wonson Vice President Of Communications 6/24/2014
Anthera Pharmaceuticals, Inc. (ANTH) Appoints Brian R. Mueller To Board Of Directors 6/24/2014
ForSight VISION5 Names Charles Semba, MD As Chief Medical Officer 6/24/2014
ProSensa Holding N.V. (RNA)'s Hans Schikan Appointed To The Biotechnology Industry Organization (BIO)'s Emerging Companies Section Governing Board 6/24/2014
Cara Therapeutics, Inc. (CARA) Announces Appointment Of Robert Medve, M.D., As Chief Medical Officer 6/24/2014
AntriaBio Appoints C. Ronald Kahn, M.D. To Its Scientific Advisory Board 6/24/2014
Astellas Pharma US Appoints Karl Uhlendorf As Communications And Advocacy Director 6/24/2014
Versartis, Inc. (VSAR) Appoints Endocrinologist Bert Bakker, MD, PhD, As Senior Vice President, Medical Affairs 6/23/2014
Chimerix, Inc. (CMRX) Announces New Directors 6/23/2014
Lion Biotechnologies, Inc. Appoints Dr. Laszlo Radvanyi As Chief Scientific Officer 6/23/2014
Landauer (LDR) Appoints Mark Zorko As Interim Chief Financial Officer 6/23/2014
Barry Lederman Appointed Vice President And Chief Financial Officer Of Eisai Inc. (ESALF.PK) 6/23/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Appointment Of C. David Nicholson, Phd To Lead Actavis Global Brands Research And Development 6/23/2014
Tobira Therapeutics Inc. Adds To Its Board Of Directors 6/23/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Three Key Appointments To Its Global Management Team 6/23/2014
PuriCore Board Changes 6/23/2014
Noven Pharmaceuticals Inc. Appoints Krista Roberts As Vice President Of Operations 6/23/2014
Merck & Co., Inc. (MRK) Names Michael J. Holston As Future General Counsel; Will Succeed Bruce N. Kuhlik In July 2015 6/23/2014
Pernix Therapeutics, Inc. (PTX) Appoints Chief Financial Officer 6/23/2014
Microsoft Executive Michael D. Robinson Joins NovoDynamics Board 6/23/2014
Life Sciences Hub Wales - Announcement Of COO And Board 6/23/2014
N8 Respiratory Hires Industry Leader As Chief Operating Officer 6/23/2014
XBiotech Announces Addition Of Vice President Of Clinical Operations 6/23/2014
Aratana Therapeutics (PETX) Adds Robert P. Roche, Jr. To Board Of Directors 6/23/2014
Russell Katz Appointed U.S. Account Manager Of m2p-labs 6/23/2014
Summit Corporation Appoints Erik Ostrowski As Chief Financial Officer 6/23/2014
Mast Therapeutics (MSTX) Announces Appointment Of Howard C. Dittrich M.D. To Board of Directors 6/20/2014
Veteran Genomic Health, Inc. (GHDX) Executive, Dean Schorno, CPA, Joins Adaptive Biotechnologies As Chief Financial Officer 6/20/2014
ProtoKinetix Inc. (PKTX.OB) Welcomes Clarence E. Smith To Its Board Of Directors 6/20/2014
H.C. Wainwright Further Expands Its Biotechnology Practice With Four Senior Level Hires 6/20/2014
Novavax, Inc. (NVAX) Announces Management Promotions 6/20/2014
Relypsa, Inc. (RLYP) Adds Industry Veterans Daniel K. Spiegelman And Kenneth J. Hillan To Its Board Of Directors 6/20/2014
Sangamo BioSciences, Inc. (SGMO) Appoints H. Stewart Parker To Its Board Of Directors 6/19/2014
Neurotrope Appoints Charles S. Ramat And Paul Freiman As Co-Chairmen Of The Board 6/19/2014
Stephen Ritter Joins Emotient As Senior Vice President Of Product Development 6/19/2014
Piper Jaffray Expands Biotechnology Investment Banking Team With Addition Of Chris Collins 6/19/2014
InVivo Therapeutics Corporation (NVIV) Appoints Steven McAllister As CFO 6/19/2014
Long-Time Novavax, Inc. (NVAX) Board Member Jack Marsh Assumes Role of Director Emeritus 6/19/2014
Aldeyra Therapeutics (ALDX) Appoints Stephen Tulipano Chief Financial Officer 6/19/2014
James Bartley, MD, PhD; FACMG, Evan Jones, MBA; Matthew Rabinowitz, PhD; And David A.H. Whiteman, MD Elected To ACMG Foundation For Genetic And Genomic Medicine Board Of Directors 6/19/2014



//-->